Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer

Activation of c-MET through hepatocyte growth factor (HGF) increases tumorigenesis, induces resistance, and is associated with poor prognosis in various solid tumors. However, the clinical value of serum HGF (sHGF) in patients with advanced non-small cell lung cancer (NSCLC), especially those receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuji, Takahiro, Sakamori, Yuichi, Ozasa, Hiroaki, Yagi, Yoshitaka, Ajimizu, Hitomi, Yasuda, Yuto, Funazo, Tomoko, Nomizo, Takashi, Yoshida, Hironori, Nagai, Hiroki, Maeno, Ken, Oguri, Tetsuya, Hirai, Toyohiro, Kim, Young Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641091/
https://www.ncbi.nlm.nih.gov/pubmed/29069748
http://dx.doi.org/10.18632/oncotarget.17895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641091/
https://www.ncbi.nlm.nih.gov/pubmed/29069748
http://dx.doi.org/10.18632/oncotarget.17895

Ejemplares similares